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We read with interest the paper by Tseng et al. [1] reporting an association with 
uterine myomas and ovarian cancer. If this were a valid observation it would be of great 
concern to many women, in addition to the currently topical issues of morcellation and 
leiomyosarcomas [2], however we believe there are several methodological issues which may 
account for these unexpected results.
The participants in this study were stratified by age, urbanization level, insurance premiums 
and date of cancer diagnosis, but there was no such stratification by factors which are known 
to affect the development of ovarian cancer, such as parity and oral contraceptive use [3], or 
ethnicity. These categories would have been more relevant for frequency-matching than some 
of the more arbitrary groups chosen in this study, and the omission of this data in the results 
in our view limits confidence of the findings.
We have particular concerns about the inclusion criteria for the definition of uterine myoma, 
which consist of a relevant International Classification of Diseases-9 code along with a 
requirement to have 3 outpatient or 1 inpatient hospital visits in the year preceding diagnosis. 
Such requirements reduce the accuracy of diagnosis rather than increase it as claimed by 
the authors, and may be responsible for much of the observed association with ovarian 
cancer. This excludes many or even most patients with myomas, particularly those which are 
asymptomatic, and therefore significantly under-represents the true prevalence of myomas 
in the population. Asymptomatic myomas account for around 50% of the total burden, 
and at least 50% of patients with no previous history have new myomas diagnosed on 
routine ultrasound screening [4]. It is unclear whether these hospital visits prior to myoma 
diagnosis relate to that myoma diagnosis, or to any other complaint. If these are not limited 
to myomas, it introduces a potentially very significant confounder; that patients who attend 
hospital more frequently may be more likely to develop ovarian cancer, irrespective of myoma 
diagnosis. It is known that ovarian cancer presents with vague and variable symptoms [5], 
and so patients who attend hospital multiple times may be more likely to be diagnosed with 
incidental myomas as part of diagnostic work-up. For these incidental cases, we would expect 
a shorter interval between myoma and ovarian cancer diagnoses, however no such timescales 
are given. This could also explain why after myomectomy women are at decreased risk as they 
would have fewer visits to hospital.
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►  See the article “Prior uterine myoma and risk of ovarian cancer: a population-based case-control 
study” in volume 30, e72.
Unless such issues can be addressed, the authors' current approach may only serve to 
increase women's anxiety, and add an unnecessary red flag for women with uterine fibroids.
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